Does RALTEGRAVIR Cause Neoplasm progression? 34 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Neoplasm progression have been filed in association with RALTEGRAVIR (ISENTRESS). This represents 0.4% of all adverse event reports for RALTEGRAVIR.
34
Reports of Neoplasm progression with RALTEGRAVIR
0.4%
of all RALTEGRAVIR reports
0
Deaths
6
Hospitalizations
How Dangerous Is Neoplasm progression From RALTEGRAVIR?
Of the 34 reports, 6 (17.6%) required hospitalization.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RALTEGRAVIR. However, 34 reports have been filed with the FAERS database.
What Other Side Effects Does RALTEGRAVIR Cause?
Foetal exposure during pregnancy (1,033)
Maternal exposure during pregnancy (726)
Exposure during pregnancy (700)
Drug interaction (552)
Virologic failure (517)
Depression (482)
Death (431)
Pathogen resistance (425)
Drug resistance (388)
No adverse event (339)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which RALTEGRAVIR Alternatives Have Lower Neoplasm progression Risk?
RALTEGRAVIR vs RALTITREXED
RALTEGRAVIR vs RAMELTEON
RALTEGRAVIR vs RAMIPRIL
RALTEGRAVIR vs RAMUCIRUMAB
RALTEGRAVIR vs RANEXA